Business Description
Shandong Boyuan Pharmaceutical and Chemical Co Ltd
Description
Financial Strength
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 926.33 | |||||
Equity-to-Asset | 0.85 | |||||
Interest Coverage | 355.96 | |||||
Piotroski F-Score | N/A/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 37.1 | |||||
3-Year EBITDA Growth Rate | 34.7 | |||||
3-Year EPS without NRI Growth Rate | 39.2 | |||||
3-Year FCF Growth Rate | 89.5 | |||||
3-Year Book Growth Rate | 37.4 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 3.95 | |||||
Quick Ratio | 2.88 | |||||
Cash Ratio | 1.8 | |||||
Days Inventory | 132.43 | |||||
Days Sales Outstanding | 71.37 | |||||
Days Payable | 104.08 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -1.7 |
Profitability Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 22.13 | |||||
Operating Margin % | 16.4 | |||||
Net Margin % | 14.76 | |||||
FCF Margin % | 13.43 | |||||
ROE % | 9.61 | |||||
ROA % | 7.96 | |||||
ROIC % | 13.06 | |||||
ROC (Joel Greenblatt) % | 19.24 | |||||
ROCE % | 10.83 | |||||
Years of Profitability over Past 10-Year | 5 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 46.19 | |||||
PE Ratio without NRI | 47.33 | |||||
PS Ratio | 6.83 | |||||
PB Ratio | 5.48 | |||||
Price-to-Tangible-Book | 5.81 | |||||
Price-to-Free-Cash-Flow | 50.83 | |||||
Price-to-Operating-Cash-Flow | 27.53 | |||||
EV-to-EBIT | 51.96 | |||||
EV-to-EBITDA | 51.96 | |||||
EV-to-Revenue | 8.64 | |||||
EV-to-FCF | 65.97 | |||||
Price-to-Graham-Number | 2.9 | |||||
Price-to-Net-Current-Asset-Value | 10.52 | |||||
Price-to-Net-Cash | 38.96 | |||||
Earnings Yield (Greenblatt) % | 1.92 | |||||
FCF Yield % | 1.48 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Shandong Boyuan Pharmaceutical and Chemical Co Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ¥) | 590.332 | ||
EPS (TTM) (Â¥) | 1.13 | ||
Beta | 0 | ||
Volatility % | 0 | ||
14-Day RSI | 0 | ||
14-Day ATR (Â¥) | 0 | ||
20-Day SMA (Â¥) | 0 | ||
12-1 Month Momentum % | 0 | ||
52-Week Range (Â¥) | 51.9 - 107.66 | ||
Shares Outstanding (Mil) | 102.8 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 9999 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Shandong Boyuan Pharmaceutical and Chemical Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Shandong Boyuan Pharmaceutical and Chemical Co Ltd Stock Events
Event | Date | Price(Â¥) | ||
---|---|---|---|---|
No Event Data |
Shandong Boyuan Pharmaceutical and Chemical Co Ltd Frequently Asked Questions
What is Shandong Boyuan Pharmaceutical and Chemical Co Ltd(SZSE:301617)'s stock price today?
When is next earnings date of Shandong Boyuan Pharmaceutical and Chemical Co Ltd(SZSE:301617)?
Does Shandong Boyuan Pharmaceutical and Chemical Co Ltd(SZSE:301617) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |